(R)-2-((S)-3-([1,1'-biphenyl]-4-yl)-2-((S)-2-(4-aminobutanamido)-3-(1H-indol-3-yl)propanamido)propanamido)-6-guanidinohexanamide

ID: ALA4872516

PubChem CID: 164623022

Max Phase: Preclinical

Molecular Formula: C37H47N9O4

Molecular Weight: 681.84

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O

Standard InChI:  InChI=1S/C37H47N9O4/c38-19-8-14-33(47)44-32(22-27-23-43-29-12-5-4-11-28(27)29)36(50)46-31(21-24-15-17-26(18-16-24)25-9-2-1-3-10-25)35(49)45-30(34(39)48)13-6-7-20-42-37(40)41/h1-5,9-12,15-18,23,30-32,43H,6-8,13-14,19-22,38H2,(H2,39,48)(H,44,47)(H,45,49)(H,46,50)(H4,40,41,42)/t30-,31+,32+/m1/s1

Standard InChI Key:  HFNDZCHWNZIJBF-RTOKGZNSSA-N

Molfile:  

 
     RDKit          2D

 50 53  0  0  0  0  0  0  0  0999 V2000
   21.5275   -7.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5263   -8.1731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2412   -8.5860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9576   -8.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9547   -7.3421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2394   -6.9329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6727   -8.5840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6691   -9.4094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3833   -9.8206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0982   -9.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0943   -8.5777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3794   -8.1701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8130   -6.9334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8128   -6.1084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0982   -5.6961    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5271   -5.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2417   -6.1080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9560   -5.6953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6706   -6.1077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3849   -5.6950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6708   -6.9327    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.5269   -4.8708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3839   -6.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6692   -5.6965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3840   -6.9338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9549   -6.1091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2403   -5.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5259   -6.1095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2401   -4.8718    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.6691   -4.8715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3835   -4.4588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1394   -4.7996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6912   -4.1864    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4717   -3.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2801   -3.4738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5358   -2.6901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9837   -2.0757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1730   -2.2503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9213   -3.0337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9558   -4.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6702   -4.4577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6700   -3.6327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3843   -3.2200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3841   -2.3950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.0985   -1.9824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0983   -1.1574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.8131   -2.3947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8114   -5.6971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0970   -6.1098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3825   -5.6975    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  1 13  1  0
 14 13  1  6
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 16 22  2  0
 15 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 24 30  1  1
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 35  1  0
 34 31  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
 18 40  1  6
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  2  0
 45 47  1  0
 28 48  1  0
 48 49  1  0
 49 50  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872516

    ---

Associated Targets(Human)

EPHA4 Tchem Ephrin type-A receptor 4 (2022 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 681.84Molecular Weight (Monoisotopic): 681.3751AlogP: 1.95#Rotatable Bonds: 19
Polar Surface Area: 234.10Molecular Species: BASEHBA: 6HBD: 9
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.21CX Basic pKa: 11.82CX LogP: 1.16CX LogD: -3.32
Aromatic Rings: 4Heavy Atoms: 50QED Weighted: 0.04Np Likeness Score: 0.00

References

1. Baggio C, Kulinich A, Dennys CN, Rodrigo R, Meyer K, Ethell I, Pellecchia M..  (2021)  NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.,  64  (15.0): [PMID:34293864] [10.1021/acs.jmedchem.1c00608]

Source